Lianchun Xiao

The University of Texas MD Anderson Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 29 papers. Top paper: “Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial”.

Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial

The Lancet. Gastroenterology & hepatology(2022)10.1016/s2468-1253(21)00427-1

N/A

4.7DataRank · unranked

263 citations

Elshad Hasanov, Hop Sanderson Tran Cao, Lianchun Xiao, Jean‐Nicolas Vauthey, Sunyoung S. Lee +24 more

Effects of a Pragmatic Home-based Exercise Program Concurrent With Neoadjuvant Therapy on Physical Function of Patients With Pancreatic Cancer

Annals of Surgery(2023)10.1097/sla.0000000000005878

N/A

1.5DataRank · unranked

43 citations

Nathan H. Parker, Lianchun Xiao, Keri Schadler, Maria Q. B. Petzel, Laura R. Prakash +18 more

Nivolumab maintenance in high-risk acute myeloid leukemia patients: a single-arm, open-label, phase II study

Blood Cancer Journal(2021)10.1038/s41408-021-00453-z

N/A

1.4DataRank · unranked

45 citations

Hagop M. Kantarjian, Farhad Ravandi, Elias Jabbour, Courtney D. DiNardo, Naval Daver +12 more

A phase 1/2 study of mini-hyper-CVD plus venetoclax in patients with relapsed/refractory acute lymphoblastic leukemia

Blood Advances(2024)10.1182/bloodadvances.2023012231

N/A

0.940DataRank · unranked

34 citations

Elias Jabbour, Nitin Jain, Jayastu Senapati, Lewis Nasr, Fadi Haddad +18 more

Association between bariatric surgery and outcomes in chronic myeloid leukemia

Cancer(2023)10.1002/cncr.34725

N/A

0.593DataRank · unranked

11 citations

Hagop M. Kantarjian, Aram Bidikian, Elias Jabbour, Nicholas J. Short, Jing Ning +10 more

Lenvatinib with or Without Everolimus in Patients with Metastatic Renal Cell Carcinoma After Immune Checkpoint Inhibitors and Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitor Therapies

The Oncologist(2021)10.1002/onco.13770

N/A

0.546DataRank · unranked

37 citations

Tharakeswara Bathala, Andrew W. Hahn, Lianchun Xiao, Munevver Duran, Jeremy A. Ross +6 more

Blockade of growth hormone receptor signaling by using pegvisomant: A functional therapeutic strategy in hepatocellular carcinoma

Frontiers in Oncology(2022)10.3389/fonc.2022.986305

N/A

0.489DataRank · unranked

25 citations

Abedul Haque, Deeksha Vishwamitra, Manal M. Hassan, Lianchun Xiao, Bhawana George +11 more

Phase 1/2 trial of encorafenib, cetuximab, and nivolumab in microsatellite stable BRAFV600E metastatic colorectal cancer

Cancer Cell(2025)10.1016/j.ccell.2025.08.002

N/A

0.477DataRank · unranked

23 citations

Christine M. Parseghian, Vahid Bahrambeigi, Nourhan Abdelfattah, Lianchun Xiao, Anjali Agrawal +28 more

Antibiotic Exposure Does Not Impact Immune Checkpoint Blockade Response in MSI-H/dMMR Metastatic Colorectal Cancer: A Single-Center Experience

The Oncologist(2022)10.1093/oncolo/oyac162

N/A

0.464DataRank · unranked

21 citations

Jane E. Rogers, Hyunsoo Hwang, Wei Qiao, Lianchun Xiao, Arvind Dasari +11 more

Plasma growth hormone is a potential biomarker of response to atezolizumab and bevacizumab in advanced hepatocellular carcinoma patients

Oncotarget(2022)10.18632/oncotarget.28322

N/A

0.434DataRank · unranked

17 citations

Dan G. Duda, Muhammad O. Awiwi, Sunyoung S. Lee, Lina Altameemi, Lianchun Xiao +13 more

Phase 1b Trial Evaluating Tolerability and Activity of Targeted Fibroblast Growth Factor Receptor Inhibition in Localized Upper Tract Urothelial Carcinoma

The Journal of Urology(2024)10.1097/ju.0000000000003928

N/A

0.411DataRank · unranked

8 citations

Mehrad Adibi, Amishi Y. Shah, Omar Alhalabi, Paul G. Corn, Charles C. Guo +8 more

A prospective parallel design study testing non-inferiority of customized oral stents made using 3D printing or manually fabricated methods

Oral Oncology(2020)10.1016/j.oraloncology.2020.104665

N/A

0.406DataRank · unranked

14 citations

Eugene J. Koay, Nimit Bajaj, Ryan Mathew, Lianchun Xiao, Anshuman Agrawal +16 more

Phase I trial of single-photon emission computed tomography–guided liver-directed radiotherapy for patients with low functional liver volume

JNCI Cancer Spectrum(2024)10.1093/jncics/pkae037

N/A

0.340DataRank · unranked

6 citations

Franklin C. Wong, Beth Chasen, William D. Erwin, Prajnan Das, Emma B. Holliday +27 more

Circulating Galectin-3: A Prognostic Biomarker in Hepatocellular Carcinoma

Journal of Immunotherapy and Precision Oncology(2024)10.36401/jipo-24-6

N/A

0.330DataRank · unranked

8 citations

Betül Gök Yavuz, Yehia I. Mohamed, Sunyoung S. Lee, James C. Yao, Zishuo Ian Hu +13 more

Communication Frameworks for Palliative Surgical Consultations

Annals of Surgery(2023)10.1097/sla.0000000000005823

N/A

0.269DataRank · unranked

5 citations

Kristen A. Robinson, Caitlin Hodge, Lianchun Xiao, Elizabeth J. Lilley, James F. Griffin +6 more

Mini-hyper-CVD plus venetoclax and navitoclax for relapsed/refractory acute lymphoblastic leukemia

Blood Advances(2025)10.1182/bloodadvances.2025016565

N/A

0.208DataRank · unranked

3 citations

Hagop M. Kantarjian, Nitin B. Jain, Tapan M. Kadia, Jayastu Senapati, Fadi Haddad +12 more

A phase 2 study of decitabine with or without carboplatin and arsenic trioxide in patients with MDS and AML

Blood Neoplasia(2025)10.1016/j.bneo.2025.100071

N/A

0.166DataRank · unranked

2 citations

Woonbok Chung, Raji Shameem, Lianchun Xiao, Curt Balch, Xuelin Huang +2 more

Angiotensin II receptor inhibition ameliorates liver fibrosis and enhances hepatocellular carcinoma infiltration by effector T cells

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.03.05.531188

N/A

0DataRank · unranked

5 citations

Yahui Zhu, Maiya Lee, Albert Nguyen, Nicolas T. Ryujin, Jian Yu Huang +7 more

N-BLR, a primate-specific non-coding transcript leads to colorectal cancer invasion and migration

UNC Libraries(2020)10.17615/mbqx-8p95

N/A

0DataRank · unranked

0 citations

Gabriel Lopez‐Berestein, Chang Gong Liu, Su Youn Nam, Jing Yi, Manel Esteller +43 more

Disruption of Growth Hormone Receptor Signaling Abrogates Hepatocellular Carcinoma Development

Journal of Hepatocellular Carcinoma(2022)10.2147/jhc.s368208

N/A

0DataRank · unranked

23 citations

Vishal Sahu, Jamie Lombardo, Lianchun Xiao, Bhawana George, Robert A. Wolff +6 more

Circulating tumor DNA (ctDNA) as a biomarker of response to therapy in advanced Hepatocellular carcinoma treated with Nivolumab

Cancer Biomarkers(2024)10.3233/cbm-230431

N/A

0DataRank · unranked

12 citations

Sunyoung S. Lee, Tarık Demir, Shadi Chamseddine, Zishuo Ian Hu, Lianchun Xiao +17 more

IGF-1 Child-Turcotte-Pugh score as a predictor of overall survival to therapy in CTP-A, BCLC stage C patients with advanced hepatocellular carcinoma.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.4_suppl.488

N/A

0DataRank · unranked

0 citations

Aliya Qayyum, Manal M. Hassan, Lianchun Xiao, Dan G. Duda, Rikita Hatia +8 more

Plasma Growth Hormone as a Prognostic Biomarker to Durvalumab and Tremelimumab in Patients with Advanced Hepatocellular Carcinoma

Journal of Hepatocellular Carcinoma(2024)10.2147/jhc.s452564

N/A

0DataRank · unranked

2 citations

Michael LaPelusa, Lianchun Xiao, Yehia I. Mohamed, Sunyoung Lee, Zishuo Hu +8 more

IGF-Child-Turcotte-Pugh score as a predictor of treatment outcome in Child-Pugh A, advanced hepatocellular carcinoma patients undergoing sorafenib therapy.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.e16660

N/A

0DataRank · unranked

1 citations

Aliya Qayyum, Manal M. Hassan, Lianchun Xiao, Dan G. Duda, Rikita Hatia +9 more

Automated, Real-Time Integration of Biometric Data From Wearable Devices With Electronic Medical Records: A Feasibility Study

JCO Clinical Cancer Informatics(2024)10.1200/cci.24.00040

N/A

0DataRank · unranked

13 citations

Ritupreet Virk, Kels Kaiser, Karen E. Hoffman, Chelain R. Goodman, Melissa Mitchell +8 more

Angiotensin II receptor inhibition ameliorates liver fibrosis and enhances hepatocellular carcinoma infiltration by effector T cells

Proceedings of the National Academy of Sciences(2023)10.1073/pnas.2300706120

N/A

0DataRank · unranked

46 citations

Yahui Zhu, Maiya Lee, Albert Nguyen, Nicolas T. Ryujin, Jian Yu Huang +8 more

Insulin-like growth factor 1/Child-Turcotte-Pugh composite score as a predictor of treatment outcomes in patients with advanced hepatocellular carcinoma treated with sorafenib

Oncotarget(2021)10.18632/oncotarget.27924

N/A

0DataRank · unranked

3 citations

Sunyoung Lee, Lianchun Xiao, Manal M. Hassan, Aliya Qayyum, Rikita Hiatia +12 more

Genomic Sequencing and Insight into Clinical Heterogeneity and Prognostic Pathway Genes in Patients with Metastatic Colorectal Cancer

Journal of the American College of Surgeons(2021)10.1016/j.jamcollsurg.2021.05.027

N/A

0DataRank · unranked

39 citations

Scott Kopetz, Lawrence N. Kwong, Lianchun Xiao, Jeffrey S. Morris, Hop S. Tran Cao +5 more

Development of a Novel Comprehensive Hepatocellular Carcinoma Outcome Prognostic Scoring System With Integration of Imaging Features

The Oncologist(2023)10.1093/oncolo/oyad329

N/A

0DataRank · unranked

1 citations

Russell G. Witt, Khaled M. Elsayes, Ali Baiomy, Lianchun Xiao, Sarah Palmquist +14 more